Fig. 1From: A prognostic model based on cell-cycle control predicts outcome of breast cancer patientsKaplan-Meier curves show the survival difference between favorable (curve a: low immunoexpressions for Securin, Separase and Cdk1) vs unfavorable (curve b: high expressions of Securin, Separase and Cdk1) outcome of the prognostic model for all breast carcinomas (a) and for subgroups with N+ (b) and N- (c) disease (cohort I, n = 781)Back to article page